The NHS Diabetic Eye Screening (DES) Programme helps prevent sight loss in people with diabetes. Screening can detect diabetic retinopathy early, when treatment is effective at reducing or preventing damage from the condition.
Dr Peter Scanlon
Dr Peter Scanlon is Clinical Director of the NHS Diabetic Eye Screening Programme. With the support and co-operation of colleagues, he helped move screening from limited ad hoc delivery of services to a systematic quality assured programme for all people with diabetes aged 12 and over in England. He is a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and Visiting Professor at the University of Gloucestershire.